GlaxoSmithKline plc EV - Enterprise Value 2011-2026 | GSK

Annual EV - Enterprise Value GlaxoSmithKline plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
42.5 B	43.3 B	46.3 B	260 B	131 B	145 B	134 B	14.1 B	35.8 B	55.2 B	70.1 B	91.2 B	77.3 B	81 B

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
260 B	14.1 B	87.6 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Adagene ADAG	395 M	$ 2.62	28.82 %	$ 147 M	China
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.51	7.34 %	$ 8.45 B	Australia
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Grifols, S.A. GRFS	11.8 B	$ 9.25	1.49 %	$ 6.83 B	Spain
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	725 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	2 B	$ 25.92	-0.86 %	$ 1.26 B	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Galapagos NV GLPG	1.17 B	$ 34.61	0.61 %	$ 2.69 B	Belgium
Ultragenyx Pharmaceutical RARE	5.05 B	$ 24.45	4.49 %	$ 2.21 B	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
BioLineRx Ltd. BLRX	15 M	$ 3.1	4.49 %	$ 908 M	Israel
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
BioNTech SE BNTX	-6.64 B	$ 116.27	-1.86 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Ascendis Pharma A/S ASND	726 M	$ 235.41	2.95 %	$ 5 B	Danmark
BioXcel Therapeutics BTAI	107 M	$ 1.84	1.66 %	$ 4.66 M	USA
Burford Capital Limited BUR	3.22 B	$ 9.74	-1.37 %	$ 1.55 B	Britain
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	-15.2 M	$ 2.66	-1.85 %	$ 16.7 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	6.02 B	$ 67.49	-3.02 %	$ 9.03 B	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 4.51	8.41 %	$ 9.81 B	Israel
BeiGene, Ltd. BGNE	253 B	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	-9.74 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	929 M	$ 2.04	28.3 %	$ 192 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	28.3 B	$ 171.89	-1.1 %	$ 25 B	USA
Bio-Path Holdings BPTH	4.67 M	-	-	$ 100 K	USA
BioVie BIVI	-12.6 M	$ 1.2	-3.7 %	$ 1.77 M	USA